Probi AB (publ)'s (STO:PROB) Price Is Right But Growth Is Lacking After Shares Rocket 31%
Nov 21
Have your own idea? Try our Stock Screener
Swedish (OMX) Healthcare Sector Analysis
UpdatedNov 23, 2024
DataAggregated Company Financials
Companies179
- 7D-0.7%
- 3M-8.6%
- 1Y9.1%
- YTD1.2%
Over the last 7 days, the Healthcare industry has dropped 6.1%, driven by Getinge declining 6.9%. On the other hand Probi is actually up 34%. Over the past 12 months, the industry was up 7.6%. As for the next few years, earnings are expected to grow by 44% per annum.
Sector Valuation and Performance
Has the Swedish Healthcare Sector valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Sun, 24 Nov 2024 | SEK 506.5b | SEK 199.8b | -SEK 2,658,058,690.15 | 36.2x | -190.6x | 2.5x |
| Tue, 22 Oct 2024 | SEK 596.7b | SEK 198.9b | -SEK 3,206,372,252.88 | 41.7x | -186.1x | 3x |
| Thu, 19 Sep 2024 | SEK 616.7b | SEK 200.1b | -SEK 2,795,442,136.94 | 40.9x | -220.6x | 3.1x |
| Sat, 17 Aug 2024 | SEK 599.0b | SEK 199.9b | -SEK 2,540,884,670.98 | 41x | -235.8x | 3x |
| Mon, 15 Jul 2024 | SEK 585.4b | SEK 196.2b | -SEK 3,104,678,694.32 | 38.3x | -188.5x | 3x |
| Wed, 12 Jun 2024 | SEK 557.0b | SEK 195.5b | -SEK 3,081,091,991.85 | 35.6x | -180.8x | 2.8x |
| Fri, 10 May 2024 | SEK 545.0b | SEK 196.8b | -SEK 2,715,029,099.51 | 35.5x | -200.7x | 2.8x |
| Sun, 07 Apr 2024 | SEK 523.8b | SEK 192.8b | -SEK 3,173,203,050.43 | 45.6x | -165.1x | 2.7x |
| Tue, 05 Mar 2024 | SEK 508.0b | SEK 192.2b | -SEK 3,659,835,641.32 | 44.4x | -138.8x | 2.6x |
| Thu, 01 Feb 2024 | SEK 656.1b | SEK 191.7b | -SEK 795,100,988.00 | 48.4x | -825.1x | 3.4x |
| Sat, 30 Dec 2023 | SEK 542.0b | SEK 191.2b | -SEK 963,322,468.00 | 48.2x | -562.6x | 2.8x |
| Mon, 27 Nov 2023 | SEK 501.3b | SEK 190.1b | -SEK 1,201,055,298.00 | 50.2x | -417.4x | 2.6x |
| Wed, 25 Oct 2023 | SEK 424.7b | SEK 186.5b | -SEK 1,835,419,558.00 | 34.7x | -231.4x | 2.3x |
| Fri, 22 Sep 2023 | SEK 459.7b | SEK 185.7b | -SEK 2,030,087,413.00 | 36.5x | -226.4x | 2.5x |
| Sun, 20 Aug 2023 | SEK 457.5b | SEK 185.0b | -SEK 1,091,744,910.00 | 37.5x | -419.1x | 2.5x |
| Tue, 18 Jul 2023 | SEK 462.9b | SEK 179.9b | -SEK 1,545,729,692.00 | 44.7x | -299.5x | 2.6x |
| Thu, 15 Jun 2023 | SEK 523.3b | SEK 178.9b | -SEK 772,164,165.00 | 45.9x | -677.6x | 2.9x |
| Sat, 13 May 2023 | SEK 518.0b | SEK 177.0b | -SEK 880,129,490.00 | 42.2x | -588.5x | 2.9x |
| Mon, 10 Apr 2023 | SEK 504.0b | SEK 172.7b | -SEK 1,424,880,805.00 | 35.7x | -353.7x | 2.9x |
| Wed, 08 Mar 2023 | SEK 491.6b | SEK 172.1b | -SEK 1,162,332,437.00 | 38.7x | -423x | 2.9x |
| Fri, 03 Feb 2023 | SEK 530.9b | SEK 166.7b | SEK 282.7m | 36.1x | 1877.7x | 3.2x |
| Sun, 01 Jan 2023 | SEK 471.6b | SEK 165.7b | SEK 699.5m | 31.9x | 674.2x | 2.8x |
| Tue, 29 Nov 2022 | SEK 488.0b | SEK 165.0b | SEK 857.8m | 31.1x | 568.9x | 3x |
| Thu, 27 Oct 2022 | SEK 469.6b | SEK 160.9b | -SEK 25,235,927.00 | 32x | -18606.8x | 2.9x |
| Sat, 24 Sep 2022 | SEK 426.0b | SEK 159.7b | -SEK 211,575,097.00 | 26.4x | -2013.4x | 2.7x |
| Mon, 22 Aug 2022 | SEK 522.6b | SEK 157.6b | -SEK 538,910,215.00 | 30x | -969.8x | 3.3x |
| Wed, 20 Jul 2022 | SEK 511.1b | SEK 154.6b | SEK 255.8m | 28.8x | 1998.4x | 3.3x |
| Fri, 17 Jun 2022 | SEK 483.1b | SEK 155.5b | SEK 398.3m | 32.6x | 1212.7x | 3.1x |
| Sun, 15 May 2022 | SEK 530.5b | SEK 153.1b | SEK 830.8m | 43.7x | 638.6x | 3.5x |
| Tue, 12 Apr 2022 | SEK 626.3b | SEK 147.6b | SEK 1.2b | 45x | 540.4x | 4.2x |
| Thu, 10 Mar 2022 | SEK 574.6b | SEK 147.7b | SEK 1.9b | 39.6x | 305.4x | 3.9x |
| Sat, 05 Feb 2022 | SEK 644.7b | SEK 143.5b | SEK 3.0b | 46.9x | 214.3x | 4.5x |
| Mon, 03 Jan 2022 | SEK 779.8b | SEK 143.9b | SEK 3.5b | 53.3x | 223.7x | 5.4x |
| Wed, 01 Dec 2021 | SEK 752.3b | SEK 143.7b | SEK 3.5b | 50.9x | 214.4x | 5.2x |
Price to Earnings Ratio
214.4x
Current Industry PE
- Investors are pessimistic on the Swedish Healthcare industry, indicating that they anticipate long term growth rates will be lower than they have historically.
- The 3-year average PS ratio of 3.1x is higher than the industry's current PS ratio of 2.5x.
Past Earnings Growth
- Total earnings for the Healthcare industry have declined over the last three years, with the industry now making a loss overall.
- Meanwhile revenues have grown 12% per year.
- This means that although more sales are being generated, either the cost of doing business or the level of investment back into businesses has increased, which has decreased profits.
Industry Trends
Which industries have driven the changes within the Swedish Healthcare sector?
| SE Market | -0.23% | |
| Healthcare | -0.69% | |
| Healthtech | 6.33% | |
| Life Sciences | 1.74% | |
| Pharma | 0.86% | |
| Healthcare Services | -0.15% | |
| Biotech | -0.46% | |
| Medical Equipment | -2.63% | |
Industry PE
- Investors are most optimistic about the Healthtech industry even though it's trading below its 3-year average PE ratio of 199x.
- Analysts are expecting annual earnings growth of 34.4%, which is lower than the prior year's growth of 187.0% per year.
Forecasted Growth
- Analysts are most optimistic on the Pharma industry, expecting annual earnings growth of 76% over the next 5 years.
- This is better than its past earnings decline of 36% per year.
- In contrast, the Healthcare Services industry is expected to see its earnings grow by 34% per year over the next few years.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| PROB Probi | SEK 350.00 | 33.6% +SEK 1.0b | 65.1% | PE366.4x | |
| BIOA B BioArctic | SEK 189.60 | 6.0% +SEK 954.4m | -19.3% | PS100.2x | |
| VIMIAN Vimian Group | SEK 44.00 | 4.0% +SEK 889.4m | 75.2% | PE7819.7x | |
| MCAP MedCap | SEK 563.00 | 7.4% +SEK 577.5m | 83.1% | PE36.6x | |
| RAY B RaySearch Laboratories | SEK 200.00 | 7.0% +SEK 445.7m | 105.8% | PE45.3x |
